EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool

Ria Margiana

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.3908 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Ria Margiana. Beteiligte Einrichtung: Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Exosomes, Pre-Eclampsia, Mesenchymal Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 155 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia (PE) is a major gestational disorder that causes both long‐ and short‐term damage to both the mother and the fetus. Endometrium decidualization and the formation of the placenta are orchestrated by mesenchymal stem cells (MSCs). MSCs obtained from patients with PE exhibit an elevated rate of aging and apoptosis, which impairs the interplay between MSCs and endothelium, trophoblast, and immune cells in the placenta, accelerating the onset of PE. Preclinical and clinical evidence imply that the MSC‐based therapy approach for PE is prospective. Importantly, as a novel cell‐free approach, MSC‐derived exosomes can improve symptoms and maternal–fetal survival in PE models by raising cell metabolism, encouraging angiogenesis balance, and regulating immune responses. Even following allogeneic administration, the likelihood of immune rejection is very limited as a result of the small quantity of exosome membrane‐bound proteins. Furthermore, because exosomes do not expand, developing tumors is not probable. As a result, MSC‐derived exosomes show superiority over MSCs in terms of safety. For the first time, we outline the properties of MSC‐exosomes and highlight their functions and potential as a new paradigm for PE therapy in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesPre-EclampsiaMesenchymal Stem CellsFemalePregnancyHumansProspective StudiesAgingMembrane Proteins

Stichwörter der Autor:innen

angiogenesisinflammationmesenchymal stem cellspreeclampsiatreatment

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Master's Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Andrology Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

Zitieren

APA

Margiana, R. (2024). Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3908

Vancouver

Margiana R. Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3908

BibTeX
@article{Margiana2024,
  author = {Margiana, Ria},
  title = {Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.3908}
}
Kostenlos starten →